Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (371-380 of 1,112) with videos related to

Pageof 112
Sort By:
The American Journal of Cardiology|October 27, 2019
Interruption of Dual Antiplatelet Therapy Within Six Months After Coronary Stents (from the Dual Antiplatelet Therapy Study)Ada C Stefanescu Schmidt, Philippe Gabriel Steg, Robert W Yeh, et al.
Journal of the American Heart Association|April 4, 2022
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-ITSenthil Selvaraj, Deepak L Bhatt, Ph Gabriel Steg, et al.
Circulation|November 8, 2025
Anticoagulation and Antiplatelet Therapy Versus Anticoagulation Alone in Patients With Chronic Coronary Syndrome Receiving Long-term Anticoagulation: a Meta-analysis of Randomized Clinical TrialsGilles Lemesle, Romain Didier, Abdourahmane Diallo, et al.
The American Journal of Medicine|July 6, 2004
Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational studyKim A Eagle, Eva Kline-Rogers, Shaun G Goodman, et al.
Circulation|September 29, 2004
Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 RegistryNicolas Danchin, Didier Blanchard, Philippe Gabriel Steg, et al.
European Heart Journal|September 30, 2015
Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO studyEmil Hagström, Stefan K James, Maria Bertilsson, et al.
Thrombosis and Haemostasis|August 28, 2007
Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarctionMarie-Geneviève Huisse, Emilie Lanoy, Didier Tcheche, et al.
Lancet (London, England)|August 31, 2010
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trialLars Wallentin, Stefan James, Robert F Storey, et al.
American Heart Journal|November 25, 2010
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary EventsMatthew Sibbald, Andrew T Yan, Wei Huang, et al.
BMJ Open|May 26, 2026
Zoī cohort, a prospective cohort with comprehensive phenotyping for preventive medicine in France, first 1000 participants: cohort profilePierre Bauvin, Alaedine Benani, Maryne Lepoittevin, et al.
Pageof 112

Showing results (371-380 of 1,112) with videos related to

Sort By:
Pageof 112
The American Journal of Cardiology|October 27, 2019
Interruption of Dual Antiplatelet Therapy Within Six Months After Coronary Stents (from the Dual Antiplatelet Therapy Study)Ada C Stefanescu Schmidt, Philippe Gabriel Steg, Robert W Yeh, et al.
Journal of the American Heart Association|April 4, 2022
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-ITSenthil Selvaraj, Deepak L Bhatt, Ph Gabriel Steg, et al.
Circulation|November 8, 2025
Anticoagulation and Antiplatelet Therapy Versus Anticoagulation Alone in Patients With Chronic Coronary Syndrome Receiving Long-term Anticoagulation: a Meta-analysis of Randomized Clinical TrialsGilles Lemesle, Romain Didier, Abdourahmane Diallo, et al.
The American Journal of Medicine|July 6, 2004
Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational studyKim A Eagle, Eva Kline-Rogers, Shaun G Goodman, et al.
Circulation|September 29, 2004
Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 RegistryNicolas Danchin, Didier Blanchard, Philippe Gabriel Steg, et al.
European Heart Journal|September 30, 2015
Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO studyEmil Hagström, Stefan K James, Maria Bertilsson, et al.
Thrombosis and Haemostasis|August 28, 2007
Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarctionMarie-Geneviève Huisse, Emilie Lanoy, Didier Tcheche, et al.
Lancet (London, England)|August 31, 2010
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trialLars Wallentin, Stefan James, Robert F Storey, et al.
American Heart Journal|November 25, 2010
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary EventsMatthew Sibbald, Andrew T Yan, Wei Huang, et al.
BMJ Open|May 26, 2026
Zoī cohort, a prospective cohort with comprehensive phenotyping for preventive medicine in France, first 1000 participants: cohort profilePierre Bauvin, Alaedine Benani, Maryne Lepoittevin, et al.
Pageof 112